https://www.indianpharmapost.com/iregenes-parkinsons-therapy-gains-fda-designation-189342026-01-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/sigachi-industries-achieves-key-rd-milestone-in-cystic-fibrosis-apis-189482026-01-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/astrazeneca-to-withdraw-nasdaq-listings-ahead-of-nyse-direct-listing-189472026-01-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/max-institute-partners-with-intuitive-surgical-to-expand-robotic-assisted-surgery-in-india-189462026-01-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/fda-go-ahead-for-eli-lillys-therapy-for-hard-to-treat-ovarian-cancer-189452026-01-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/medico-remedies-secures-government-supply-order-of-rs-7323-cr-189442026-01-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/senores-pharmaceuticals-reports-stellar-q3-fy26-growth-pat-surges-105-189432026-01-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/hrv-pharma-sms-lifesciences-form-strategic-partnership-for-orphan-and-niche-apis-189422026-01-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/moderna-merck-study-mrna-therapy-plus-keytruda-cut-melanoma-recurrence-risk-by-half-189412026-01-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/neurizon-locks-in-global-trademark-protection-across-key-pharma-markets-189402026-01-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/novo-nordisk-deepens-aspect-biosystems-alliance-in-push-for-curative-diabetes-cell-therapies-189392026-01-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/lupin-and-galenicum-ink-license-and-supply-agreement-for-semaglutide-in-23-countries-189382026-01-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/fresenius-kabi-tq-therapeutics-join-forces-to-accelerate-cell-gene-therapy-manufacturing-189372026-01-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/brenig-therapeutics-launches-first-in-human-trial-of-novel-neurodegenerative-therapy-189362026-01-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/astrazeneca-gains-full-global-rights-to-abelzetas-car-t-therapy-in-630m-deal-189352026-01-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/tatva-chintan-pharma-chem-posts-consolidated-q3-fy26-at-rs-1516-cr-189492026-01-21T00:00:00+05:30always0.9